{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:11:38Z","timestamp":1788023498434,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Research Center KSU"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12906-017-1763-7","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T21:56:10Z","timestamp":1494366970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism"],"prefix":"10.1186","volume":"17","author":[{"given":"Maha","family":"Al-Askar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesa Shafi","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Al-Ayadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"El-Ansary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,10]]},"reference":[{"key":"1763_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1744-9081-5-11","volume":"5","author":"FJ Van der Staay","year":"2009","unstructured":"Van der Staay FJ, Arndt SS, Nordquist RE. Evaluation of animal models of neurobehavioral disorders. Behav Brain Funct. 2009;5:11.","journal-title":"Behav Brain Funct"},{"key":"1763_CR2","first-page":"116","volume":"64","author":"Z Ergaz","year":"2016","unstructured":"Ergaz Z, Weinstein-Fudim L, Ornoy A. Genetic and non-genetic animal models for autism spectrum disorders (ASD) Reprod. Toxicology. 2016;64:116\u201340.","journal-title":"Toxicology"},{"key":"1763_CR3","doi-asserted-by":"crossref","unstructured":"Kazlauskas N, Campolongo M, Lucchina L, Zappala C, Depino AM. Postnatal behavioral and inflammatory alterations in female pupsprenatally exposed to valproic acid. Psychoneuroendocrinology. 2016;72:11\u201321.","DOI":"10.1016\/j.psyneuen.2016.06.001"},{"key":"1763_CR4","doi-asserted-by":"crossref","unstructured":"Kim JW, Seung H, Kim KC, Gonzales EL, Oh HA, Yang SM, Ko MJ, Han SH, Banerjee S, Shin CY. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism. Neuropharmacology. 2017;113(Pt A):71\u201381.","DOI":"10.1016\/j.neuropharm.2016.09.014"},{"issue":"16","key":"1763_CR5","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen J, Gr\u00f8nborg TK, S\u00f8rensen MJ, Schendel D, Parner ET, Pedersen LH, Vestergaard M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309(16):1696\u2013703.","journal-title":"JAMA"},{"key":"1763_CR6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","volume":"201","author":"KC Kim","year":"2011","unstructured":"Kim KC, Kim P, Go HS, Choi CS, Yang SI, Cheong JH, Shin CY, Ko KH. The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol Lett. 2011;201:137\u201342.","journal-title":"Toxicol Lett"},{"issue":"4","key":"1763_CR7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","volume":"23","author":"Y Ghodke-Puranik","year":"2013","unstructured":"Ghodke-Puranik Y, Thorn CF, Lamba JK, Leeder JS, Song W, Birnbaum AK, Klein TE. Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2013;23(4):236\u201341.","journal-title":"Pharmacogenet Genomics"},{"key":"1763_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","volume":"9","author":"CU Johannessen","year":"2003","unstructured":"Johannessen CU, Johannessen SI. Valproate: past, present, and future. CNS Drug Rev. 2003;9:199\u2013216.","journal-title":"CNS Drug Rev"},{"key":"1763_CR9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/WCO.0b013e3283292401","volume":"22","author":"RL Bromley","year":"2009","unstructured":"Bromley RL, Baker GA, Meador KJ. Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Curr Opin Neurol. 2009;22:162\u20136.","journal-title":"Curr Opin Neurol"},{"key":"1763_CR10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.yebeh.2009.09.024","volume":"16","author":"KM McVearry","year":"2009","unstructured":"McVearry KM, Gaillard WD, VanMeter J, Meador KJ. A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy. Epilepsy Behav. 2009;16:609\u201316.","journal-title":"Epilepsy Behav"},{"issue":"Pt 2","key":"1763_CR11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/brain\/awq352","volume":"134","author":"KJ Meador","year":"2011","unstructured":"Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. NEAD Study Group Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain. 2011;134(Pt 2):396\u2013404.","journal-title":"Brain"},{"issue":"1","key":"1763_CR12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138161212798918995","volume":"18","author":"RB Mythri","year":"2012","unstructured":"Mythri RB, Bharath MM. Curcumin: a potential neuroprotective agent in Parkinson's disease. Curr Pharm Des. 2012;18(1):91\u20139.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1763_CR13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","volume":"41","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Int. J Biochem Cell Biol. 2009;41(1):40\u201359.","journal-title":"J Biochem Cell Biol"},{"key":"1763_CR14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lfs.2015.09.012","volume":"141","author":"R Bhandari","year":"2015","unstructured":"Bhandari R. Kuhad a Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders. Life Sci. 2015;141:156\u201369.","journal-title":"Life Sci"},{"issue":"1","key":"1763_CR15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","volume":"30","author":"T Schneider","year":"2005","unstructured":"Schneider T, Przew\u0142ocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology. 2005;30(1):80\u20139.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1763_CR16","first-page":"168","volume":"56","author":"B Purwar","year":"2012","unstructured":"Purwar B, Shrivastava A, Arora N, Saxena AKAY. Effects of Curcumin on the gastric emptying of albino rats. Indian J Physiol Pharmacol. 2012;56(2):168\u201373.","journal-title":"Indian J Physiol Pharmacol"},{"key":"1763_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","volume":"36","author":"FI Roullet","year":"2013","unstructured":"Roullet FI, Lai JK, Foster JA. In utero exposure to valproic acid and autism\u2013a current review of clinical and animal studies. Neurotoxicol Teratol. 2013;36:47\u201356.","journal-title":"Neurotoxicol Teratol"},{"key":"1763_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neulet.2013.04.054","volume":"547","author":"J Ma","year":"2013","unstructured":"Ma J, Liu J, Yu H, Wang Q, Chen Y, Xiang L. Curcumin promotes nerve regeneration and functional recovery in rat model of nerve crush injury. Neurosci Lett. 2013;547:26\u201331.","journal-title":"Neurosci Lett"},{"issue":"9","key":"1763_CR19","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8(9):1254\u201366.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"1763_CR20","first-page":"141","volume":"14","author":"JS Jurenka","year":"2009","unstructured":"Jurenka JS. Anti-inflammatory properties of Curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009;14(2):141\u201353.","journal-title":"Altern Med Rev"},{"key":"1763_CR21","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/mt.2008.155","volume":"16","author":"A Otsuki","year":"2008","unstructured":"Otsuki A, et al. Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses. Mol Ther. 2008;16:1546\u201355.","journal-title":"Mol Ther"},{"key":"1763_CR22","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.4049\/jimmunol.171.11.6072","volume":"171","author":"HY Kim","year":"2003","unstructured":"Kim HY, Park EJ, Joe EH, et al. Curcumin suppresses januskinase-STAT inflammatory signalling through activation of Srchomology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol. 2003;171:6072\u20139.","journal-title":"J Immunol"},{"key":"1763_CR23","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ejca.2005.05.009","volume":"41","author":"RA Sharma","year":"2005","unstructured":"Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer. 2005;41:1955\u201368.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1763_CR24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.fct.2008.11.013","volume":"47","author":"FM El-Demerdasha","year":"2009","unstructured":"El-Demerdasha FM, Yousef MI, Radwan FM. Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs. Food Chem Toxicol. 2009;47(1):249\u201354.","journal-title":"Food Chem Toxicol"},{"key":"1763_CR25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neuroscience.2012.08.060","volume":"225","author":"S Chaudhary","year":"2012","unstructured":"Chaudhary S, Parvez S. An in vitro approach to assess the neurotoxicityof valproic acid-induced oxidative stress in cerebellumand cerebral cortex of young rats. Neuroscience. 2012;225:258\u201368.","journal-title":"Neuroscience"},{"key":"1763_CR26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1357-2725(98)00015-6","volume":"30","author":"JT Piper","year":"1998","unstructured":"Piper JT, Singhal SS, Salameh M, Torman RT, Awasthi YC, Awasthi S. Mechanisms of anticarcinogenic properties ofcurcumin: the effect of curcumin on glutathione linked detoxificationenzymes in rat liver. Int J Biochem Cell Biol. 1998;30:445\u201356.","journal-title":"Int J Biochem Cell Biol"},{"key":"1763_CR27","doi-asserted-by":"publisher","DOI":"10.5772\/54824","volume-title":"Valproic acid in autism spectrum disorder: from an environmental risk factor to a reliable animal model, recent advances in autism spectrum disorders","author":"C Gottfried","year":"2013","unstructured":"Gottfried C, Bambini-Junior V, Baronio D, Zanatta G, Silvestrin RB, Vaccaro T, Riesgo R. In: Fitzgerald M, editor. ISBN: 978-953-51-1021-7, In Tech Valproic acid in autism spectrum disorder: from an environmental risk factor to a reliable animal model, recent advances in autism spectrum disorders, vol. 1; 2013. doi: 10.5772\/54824 ."},{"issue":"11","key":"1763_CR28","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.mp.4002006","volume":"12","author":"N M\u00fcller","year":"2007","unstructured":"M\u00fcller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry. 2007;12(11):988\u20131000.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1763_CR29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/1570159X11666131120223757","volume":"12","author":"G Anderson","year":"2014","unstructured":"Anderson G, Maes M. Redox regulation and the autistic Spectrum: role of tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala. Curr Neuropharmacol. 2014;12(2):148\u201367.","journal-title":"Curr Neuropharmacol"},{"key":"1763_CR30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2012.11.048","volume":"1495","author":"R Bristot Silvestrin","year":"2013","unstructured":"Bristot Silvestrin R, Bambini-Junior V, Galland F, Daniele Bobermim L, Quincozes-Santos A, Torres Abib R, Zanotto C, et al. Animal model of autism induced by prenatal exposure to valproate: altered glutamate metabolism in the hippocampus. Brain Res. 2013;1495:52\u201360.","journal-title":"Brain Res"},{"key":"1763_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2008.01.104","volume":"1210","author":"R Wang","year":"2008","unstructured":"Wang R, Li YB, Li YH, Xu Y, Wu HL, Li XJ. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res. 2008;1210:84\u201391.","journal-title":"Brain Res"},{"key":"1763_CR32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuint.2015.07.026","volume":"89","author":"S Hagl","year":"2015","unstructured":"Hagl S, Kocher A, Schiborr C, Kolesova N, Frank J, Eckert GP. Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice - impact on bioavailability. Neurochem Int. 2015;89:234\u201342.","journal-title":"Neurochem Int"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-017-1763-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T23:17:38Z","timestamp":1569280658000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-017-1763-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1186\/s12906-017-1763-7","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,10]]},"article-number":"259"}}